Stericycle, Inc. (NASDAQ:SRCL) Receives Average Recommendation of “Hold” from Brokerages

Stericycle, Inc. (NASDAQ:SRCL) has earned an average rating of “Hold” from the six ratings firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $74.00.

Several analysts have commented on the company. StockNews.com assumed coverage on Stericycle in a research note on Tuesday, September 17th. They set a “hold” rating for the company. Truist Financial upped their price objective on Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, June 4th. Keefe, Bruyette & Woods upped their price objective on Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $62.00 price objective (down from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th.

Stericycle Stock Down 0.0 %

Shares of NASDAQ SRCL opened at $61.68 on Monday. The stock has a market cap of $5.73 billion, a PE ratio of -280.36, a price-to-earnings-growth ratio of 3.37 and a beta of 1.11. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55. Stericycle has a 52-week low of $37.78 and a 52-week high of $61.77. The business has a 50-day moving average price of $59.33 and a 200 day moving average price of $54.86.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, beating the consensus estimate of $0.57 by $0.04. The firm had revenue of $661.60 million during the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. Equities research analysts forecast that Stericycle will post 2.29 earnings per share for the current year.

Hedge Funds Weigh In On Stericycle

A number of large investors have recently modified their holdings of SRCL. Vanguard Group Inc. grew its holdings in shares of Stericycle by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider’s stock worth $444,509,000 after acquiring an additional 52,576 shares during the period. Capital Research Global Investors grew its holdings in shares of Stericycle by 11.4% in the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after acquiring an additional 679,974 shares during the period. Earnest Partners LLC grew its holdings in shares of Stericycle by 12.4% in the 1st quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock worth $129,766,000 after acquiring an additional 271,025 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Stericycle by 7.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,171,659 shares of the business services provider’s stock worth $126,238,000 after acquiring an additional 142,814 shares during the period. Finally, Schroder Investment Management Group grew its holdings in shares of Stericycle by 8.1% in the 4th quarter. Schroder Investment Management Group now owns 1,739,644 shares of the business services provider’s stock worth $86,217,000 after acquiring an additional 129,822 shares during the period. 98.82% of the stock is owned by hedge funds and other institutional investors.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.